Surprisingly, the use of these cells alone was insufficient in mediating A20 lymphoma regression (Figure 1), indicating that injection of allogeneic cells and GM-CSF within evolving tumors does not generate a sufficient immune response to constrain tumor growth. The gene discussed is CSF2; the disease is lymphoma.